<DOC>
	<DOCNO>NCT01602822</DOCNO>
	<brief_summary>This study evaluate safe tolerable combination take three-drugs purpose prevent HIV transmission high-risk sexual contact exposure HIV uninfected adult .</brief_summary>
	<brief_title>Safety Acceptability Study Non-occupational Prophylaxis ( PEP ) Following Potential Exposure HIV</brief_title>
	<detailed_description>Participants give regimen contain TDF 300mg FTC 200mg fixed-dose combination tablet ( TDF/FTC ) daily , atazanavir , one 300mg tablet one 100 mg ritonavir give daily , 28 day .</detailed_description>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Atazanavir Sulfate</mesh_term>
	<mesh_term>Emtricitabine , Tenofovir Disoproxil Fumarate Drug Combination</mesh_term>
	<mesh_term>Emtricitabine</mesh_term>
	<mesh_term>Tenofovir</mesh_term>
	<criteria>1 . Age 18 time first visit . 2 . HIV uninfected basis negative HIV Rapid Test 3 . Possible nonoccupational exposure HIV1 , recent enough permit receive first dose study medication within 72 hour end exposure . 1 . Women actively try become pregnant . 2 . Pregnancy and/or Breastfeeding . 3 . Known self report Chronic Hepatitis B infection prior antiretroviral therapy hepatitis B . 4 . Known intolerance allergy study drug .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>HIV Prevention</keyword>
	<keyword>NPEP</keyword>
	<keyword>PEP</keyword>
</DOC>